OneAscent Wealth Management’s Collegium Pharmaceutical COLL Stock Holding History

OneAscent Wealth Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-11,194	Closed	-$179K	–	160
2022 Q3	$179K	Sell	11,194 -3,426	-23%	-$60.4K	0.09%	147
2022 Q2	$259K	Sell	14,620 -56	-0.4%	-$942	0.13%	135
2022 Q1	$299K	Buy	14,676 +545	+4%	+$10.3K	0.15%	146
2021 Q4	$264K	Buy	14,131 +700	+5%	+$13.6K	0.66%	62
2021 Q3	$265K	Buy	+13,431	New	+$290K	0.3%	78
2021 Q1	$442K	Sell	18,662 -2,621	-12%	-$62.3K	0.19%	128
2020 Q4	$426K	Buy	+21,283	New	+$416K	0.19%	119

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

OneAscent Wealth Management's COLL Position: Q4 2022 in Review

OneAscent Wealth Management sold out of Collegium Pharmaceutical (COLL) in Q4 2022, closing a stake of 11,194 shares — an estimated $179K sold.

OneAscent Wealth Management first reported a position in COLL in Q4 2020 and held it in 7 quarters. The position peaked at $442K in Q1 2021. 179 funds tracked by Wall St. Rank hold COLL as of Q4 2022.

OneAscent Wealth Management reported no remaining Collegium Pharmaceutical position as of Q4 2022 after selling out during the quarter.
OneAscent Wealth Management sold 11,194 Collegium Pharmaceutical shares in Q4 2022, an estimated $179K.
OneAscent Wealth Management first reported a position in Collegium Pharmaceutical in Q4 2020 and held it in 7 quarters.
OneAscent Wealth Management's Collegium Pharmaceutical position peaked at $442K in Q1 2021.
179 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2022.

Based on OneAscent Wealth Management's 13F filing for Q4 2022, filed 12 Jan 2023.